Molecular Therapy of Virus-Associated Cancers (F065), German Cancer Research Center, Im Neuenheimer Feld 242, 69120, Heidelberg, Germany.
Cell Mol Life Sci. 2010 Jun;67(11):1895-905. doi: 10.1007/s00018-010-0300-3. Epub 2010 Feb 23.
Livin (ML-IAP) is a cancer-associated member of the inhibitor of apoptosis protein (IAP) family. By yeast two-hybrid screening of a randomized peptide expression library, we isolated short linear peptides that specifically bind to Livin, but not to other IAPs. Intracellular expression of the peptides sensitized livin-expressing cancer cells toward different pro-apoptotic stimuli. The bioactive peptides neither showed sequence homologies to Smac-derived IAP inhibitors, nor did they interfere with the binding of Livin to Smac. Intracellular expression of the peptides did not affect the levels or the subcellular distribution of Livin. Growth of livin-expressing tumor cells was inhibited in colony formation assays by the Livin-targeting peptides. These findings provide evidence that the targeted inhibition of Livin by peptides represents a viable approach for the apoptotic sensitization and growth inhibition of tumor cells. The inhibitory peptides isolated here could form a novel basis for the development of therapeutically useful Livin inhibitors.
Livin(ML-IAP)是凋亡抑制蛋白(IAP)家族中的一种癌相关成员。通过随机肽表达文库的酵母双杂交筛选,我们分离出了特异性结合 Livin 而不结合其他 IAP 的短线性肽。细胞内表达这些肽可使表达 Livin 的癌细胞对不同的促凋亡刺激敏感。这些生物活性肽既与 Smac 衍生的 IAP 抑制剂没有序列同源性,也不干扰 Livin 与 Smac 的结合。肽的细胞内表达并不影响 Livin 的水平或亚细胞分布。Livin 靶向肽在集落形成测定中抑制表达 Livin 的肿瘤细胞的生长。这些发现为通过肽靶向抑制 Livin 来促进肿瘤细胞凋亡和抑制肿瘤生长提供了证据。在这里分离出的抑制肽可能为开发治疗上有用的 Livin 抑制剂提供新的基础。